Tag:
Sichuan
Latest Headlines
Latest Headlines
Chinese pharmas feel the squeeze of healthcare reform
Even though China is set to become the second-largest drug market by 2020, all is not rosy for its native drugmakers. A government push to drive down costs for healthcare end users is pressuring pharma companies that call that vast country home, with 5 of them issuing profit warnings in recent weeks.
FDA slaps Sichuan on API facility shortfalls
Sichuan Pharmaceuticals is in FDA woodshed. The agency sent a warning letter to the Chinese drugmaker, scolding it for manufacturing shortfalls at a plant in Pengzhou. During a June 2010 inspection
